Beth F. Levine, General Counsel and CCO at KERYX BIOPHARMACEUTICALS INC (KERX), bought 1,000 shares at $11.00 ($11K) on 2007-06-18, disclosed to the SEC on 2007-06-20.
Open-market purchase of $11k KERX by General Counsel and CCO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.